Jaguar Health, Inc.JAGX
Price (close)
$7.06
Market cap
—
P/E
—
Revenue (TTM)
$27.8M
Net income
-$36.5M
Dividend yield
—
1-year total return
-99.3%
Net margin
-131.4%
Revenue growth
135.5%
Debt / equity
0.26x
What Jaguar Health, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $9.4M | $4.3M | $12.0M | $9.8M | $11.7M | $11.5M |
| Net income | -$33.8M | -$52,600 | -$48,400 | -$41,900 | -$38.5M | -$53.6M |
| Free cash flow | -$15.3M | -$35.0M | -$33.2M | — | -$29.4M | — |
More on JAGX.
- Jaguar Health, Inc. summary
- Jaguar Health, Inc. financial statements
- Jaguar Health, Inc. key metrics
- Jaguar Health, Inc. health scores and style box
- Jaguar Health, Inc. earnings
- Jaguar Health, Inc. dividends
- Jaguar Health, Inc. valuation
- Jaguar Health, Inc. ownership and insiders
- Jaguar Health, Inc. peers
Figures from Jaguar Health, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.